Skip to main content
. 2017 Sep 22;7:12192. doi: 10.1038/s41598-017-12305-7

Figure 4.

Figure 4

Akt mediates the antifibrotic effect of RCN-3 in human cardiac fibroblasts. Human cardiac fibroblasts were treated with RCN-3 (0.1 µg/mL) for 5, 10, 15, 30 and 60 minutes. Effects of RCN-3 (0.1 µg/mL) on Akt (A), STAT3 (B) and ERK 1/2 (C) at 5, 10, 15, 30 and 60 minutes in human cardiac fibroblasts. Effect of PD98059 (10−5M) and Wortmannin (10−5M) on the decrease of collagen type I protein levels induced by RCN-3 (0.1 µg/mL) at 24 hours in human cardiac fibroblast (D). Histogram bars represent the mean ± SEM (n > 6 wells at 70% of confluence per condition) of the three independent experiments. Densitometry values were normalized to stain free gel. *p < 0.05; **p < 0.01; vs. Control. p < 0.05 vs. RCN-3.